5SC-11180-12275
5 vaccinations
16 coded responses
59 check-ins
15 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 980 / WA
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Moderna
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
-
2021-03-18
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: GoodFree text: Probably unrelated hand pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Moderna
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Rash, Rash erythematous, Rash pruritic — Feeling: GoodFree text: Rash on left side of my back. Red bumps that itched. This may have been from Shingrix booster immunization on 4/26/2021 (>2 weeks after 2nd Covid immunization-4/8/2021).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-10-07
Survey response — 6 months, dose 2MedDRA: Chromaturia, Headache, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Some intermittent low grade fevers/headaches and some dark (brown) urine. Both seemed to have resolved mostly.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-12
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-02
Dose 3 — Moderna
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Oral mucosal blistering — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Blisters on roof of mouthMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-08
-
2021-11-09
Survey response — day 7, dose 3MedDRA: Rash, Rash erythematous — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Lacy red rash on abdomenMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Survey response — day 14, dose 3MedDRA: Asthma, Condition aggravated, Pre-existing disease — Feeling: FairFree text: Increase in allergy/asthma type symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Survey response — day 21, dose 3MedDRA: Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: Mild symptoms of allergy:asthma worsening only slightly.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-30
- 2021-12-07
- 2021-12-14
-
2022-02-01
Survey response — 3 months, dose 3MedDRA: Sinus headache — Feeling: GoodFree text: Sinus head achesMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Survey response — 6 months, dose 3MedDRA: Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Asthma symptoms (due to seasonal allergies?)MedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Dose 4 — Moderna
- 2022-05-16
-
2022-05-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-05-20
Survey response — days 1–6 daily, dose 4MedDRA: Body temperature increased — Feeling: Fair · Site: Pain · Chills, Headache · Be unable to do your normal daily activitiesFree text: Low grade fever last night as high as 99.6MedDRA releases: 2024-11 · check-in free text available
- 2022-05-22
- 2022-05-23
- 2022-05-30
-
2022-06-08
Survey response — day 21, dose 4MedDRA: Asthma — Feeling: FairFree text: Worsened asthma symptoms.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-13
- 2022-06-20
- 2022-06-27
-
2022-08-16
Survey response — 3 months, dose 4MedDRA: Endoscopy abnormal, Gastrooesophageal reflux disease, Oesophageal disorder, Oesophageal irritation, Oesophageal mucosa erythema, Oesophagitis, Pharyngeal swelling, Pre-existing disease, Throat irritation — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I have had slowly increasing symptoms of GERD for the last year to a year and a half. A recent upper endoscopy showed erythema and furrowing in lower 2/3 of esophagus. Biopsy results still pending. Irritation/swelling present in throat/esophagus nowMedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-27
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-28
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-30
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-01
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2022-10-02
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-03
Health check-in — day 7, dose 5Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-10
- 2022-10-18
- 2022-10-24
-
2022-10-31
Survey response — day 35, dose 5MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Survey response — day 42, dose 5MedDRA: Sinus headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sinus headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-12-26
Survey response — 3 months, dose 5MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid 19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2023-03-28
Survey response — 6 months, dose 5MedDRA: Adverse reaction, COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Moderna | |
| 2 | 2021-04-08 | Moderna | |
| 3 | 2021-11-02 | Moderna | No |
| 4 | 2022-05-16 | Moderna | No |
| 5 | 2022-09-26 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): Probably unrelated hand pain.
Release 8 — day 28, dose 2
Symptoms: Rash on left side of my back. Red bumps that itched. This may have been from Shingrix booster immunization on 4/26/2021 (>2 weeks after 2nd Covid immunization-4/8/2021).
Release 10 — 6 months, dose 2
Symptoms: Some intermittent low grade fevers/headaches and some dark (brown) urine. Both seemed to have resolved mostly.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Blisters on roof of mouth
Release 10 — day 7, dose 3
Systemic reaction (other): Lacy red rash on abdomen
Release 10 — day 14, dose 3
Symptoms: Increase in allergy/asthma type symptoms
Release 10 — day 21, dose 3
Symptoms: Mild symptoms of allergy:asthma worsening only slightly.
Release 11 — 3 months, dose 3
Symptoms: Sinus head aches
Release 11 — 6 months, dose 3
Symptoms: Asthma symptoms (due to seasonal allergies?)
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Low grade fever last night as high as 99.6
Release 11 — day 21, dose 4
Symptoms: Worsened asthma symptoms.
Release 12 — 3 months, dose 4
Symptoms: I have had slowly increasing symptoms of GERD for the last year to a year and a half. A recent upper endoscopy showed erythema and furrowing in lower 2/3 of esophagus. Biopsy results still pending. Irritation/swelling present in throat/esophagus now cut off by CDC
Release 12 — day 35, dose 5
Symptoms: Fatigue
Release 12 — day 42, dose 5
Symptoms: Sinus headache
Release 12 — 3 months, dose 5
Symptoms: Covid 19 infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Chromaturia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Endoscopy abnormal | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Oesophageal disorder | · | · | ✓ |
| SD | Oesophageal irritation | · | · | ✓ |
| SD | Oesophageal mucosa erythema | · | · | ✓ |
| SD | Oesophagitis | · | · | ✓ |
| SD | Pharyngeal swelling | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | Oral mucosal blistering | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash erythematous | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release